Accelerant (ARX) to be taken private by Thoma Bravo for USD 20.25/shr

Accelerant (ARX) to be taken private by Thoma Bravo for USD 20.25/shr.

An all-cash take-private by a financial sponsor at a fixed per-share price is the cleanest form of M&A headline: the deal spread, not fundamentals, becomes the pricing problem from here. Thoma Bravo's track record is concentrated in software and technology-adjacent assets, and the firm has historically run a high volume of take-privates, typically completing rather than re-trading, though sponsor deals broadly have seen occasional price cuts or walkaways when financing conditions tightened sharply. The spread at the open will reflect perceived completion risk: financing contingencies, regulatory clearances, and any go-shop or fiduciary-out provisions are the items that determine how tight it trades. The precedent pattern for single-sponsor cash deals without antitrust overlap is a relatively narrow spread and a timeline measured in a few months, with the main tail risk being financing market stress rather than regulatory block. Worth noting is whether any outside shareholder or competing bidder emerges during the interim, since topping bids in sponsor take-privates have historically been the exception rather than the rule. The follow-ons are the proxy filing, the financing structure, and any shareholder litigation, which in deals of this kind is routine and rarely alters terms.